Scisparc – CFN Media

Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio

Tel Aviv, Israel / Vancouver, Canada, Aug. 01, 2023 — Clearmind Medicine…

Ryan Allway
August 1, 2023

Clearmind Medicine and SciSparc to Conduct Study Evaluating Combination Treatment for Obesity and Metabolic Syndrome

The treatment combines Clearmind’s MEAI, a novel proprietary psychedelic treatment for various addictions, and…

Ryan Allway
June 16, 2023

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Consumer Product Stocks

Video Review of LEEF Brands’ Investment Opportunity

Long term investor Mariusz Skonieczny recently made a video highlighting 3…

Robin Lefferts
December 23, 2024

Video Review of Aduro Clean Technologies’ Investment Opportunity

Long term investor Mariusz Skonieczny recently made a video highlighting 3…

Robin Lefferts
December 23, 2024

Healthcare Stocks

Cardiol Execs and Board Members Increase Equity, Signal Confidence

Members of the Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) executive team…

Robin Lefferts
December 23, 2024

Consumer Product Stocks

LEEF Brands Inc. Closes Second Tranche Private Placement Financing Round of CAD$500,000

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED…

Ryan Allway
December 20, 2024